Drug Trial Radar · NCT01696461
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
Last checked: Nov 20, 2026Latest source record: Sep 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
127
Actual
Start
May 2013
Primary completion
Aug 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- Center for International Blood and Marrow Transplant ResearchResearch network
- Sponsor type
- Research network
- Collaborators
- Genzyme, a Sanofi Company; Sanofi
- First posted
- Oct 1, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in recipients with hematological malignancies. This study will establish the safety and efficacy of subcutaneous plerixafor for this purpose.
Conditions
- Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member
- Acute Myelogenous Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndrome
- Chronic Myelogenous Leukemia
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
- Chronic Lymphocytic Leukemia
Interventions
PlerixaforDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Donors Whose Cells Were Successfully Mobilized and Collected With a Sufficient CD34+ Cell Dose Using Plerixafor as the Mobilizing Agent, Using an Intention-to-treat Analysis.Time frame: donation
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
H. Lee Moffitt Cancer Center
Tampa, Florida
Emory University
Atlanta, Georgia
University of Chicago
Chicago, Illinois
Massachusetts General Hospital
Boston, Massachusetts
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University
St Louis, Missouri
Duke University
Durham, North Carolina
Cleveland Clinic
Cleveland, Ohio
Ohio State University
Columbus, Ohio
West Virginia University
Morgantown, West Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.